Beevi Ss Safeena, Pottakkat Biju
Surgical Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, IND.
Cureus. 2023 Mar 30;15(3):e36923. doi: 10.7759/cureus.36923. eCollection 2023 Mar.
Background Malnutrition and liver dysfunction are commonly observed in patients with chronic liver disease. With the current surge in liver diseases, prompt nutritional planning will ensure the well-being of patients during the waiting period and will improve the clinical outcomes following liver transplantation (LT). We conducted this study to monitor the effect of immunonutrition on liver function parameters among end-stage liver disease (ESLD) patients referred for LT. Methodology In this randomized controlled trial, 144 ESLD patients who met the inclusion criteria were randomly enrolled into control (CON) and intervention (INT) groups after obtaining informed consent. Three patients were lost to follow-up due to the COVID-19 lockdown. The INT group (n = 69) was provided with 100 g of immunonutrient and the CON group (n = 72) was provided with supervised diet advice. Liver function test (LFT) parameters such as total protein, albumin, total bilirubin, direct bilirubin, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, gamma-glutamyl transferase, and prothrombin time/international normalized ratio before and after therapy at one month were checked in both groups. Results The majority of patients with the disease were males (83.3% in the CON group vs 76.8% in the INT group), having alcoholism as the etiology in both groups with 45.8% in the CON group and 56.5% in the INT group. The comparison of LFT parameters among ESLD patients during pre and post-therapy between the control and immunonutrition groups did not show any statistically significant difference in the LFT parameters between the INT and CON groups both at baseline and at one month. Conclusions The impact of immunonutrition on ESLD patients awaiting LT compared to supervised diet advice did not significantly improve liver function. The liver disease itself profoundly affects the level of nutrition; hence, nutritional assessment and early nutritional interventions can be instituted to improve clinical outcomes.
慢性肝病患者中普遍存在营养不良和肝功能障碍。随着当前肝病的激增,及时的营养规划将确保患者在等待期的健康,并改善肝移植(LT)后的临床结局。我们进行这项研究以监测免疫营养对转诊接受LT的终末期肝病(ESLD)患者肝功能参数的影响。
在这项随机对照试验中,144名符合纳入标准的ESLD患者在获得知情同意后被随机分为对照组(CON)和干预组(INT)。由于COVID-19封锁,有3名患者失访。INT组(n = 69)接受100克免疫营养素,CON组(n = 72)接受监督饮食建议。在两组中检查治疗前后1个月时的肝功能测试(LFT)参数,如总蛋白、白蛋白、总胆红素、直接胆红素、天冬氨酸转氨酶、丙氨酸转氨酶、碱性磷酸酶、γ-谷氨酰转移酶和凝血酶原时间/国际标准化比值。
大多数患者为男性(CON组为83.3%,INT组为76.8%),两组病因均为酒精中毒,CON组为45.8%,INT组为56.5%。在对照组和免疫营养组的ESLD患者治疗前和治疗后的LFT参数比较中,INT组和CON组在基线和1个月时的LFT参数均未显示出任何统计学上的显著差异。
与监督饮食建议相比,免疫营养对等待LT的ESLD患者的影响并未显著改善肝功能。肝病本身对营养水平有深远影响;因此,可以进行营养评估和早期营养干预以改善临床结局。